Skip to main content
. 2018 Feb 14;8:2989. doi: 10.1038/s41598-018-21179-2

Figure 2.

Figure 2

Serial changes in Ishak fibrosis scores and qFibrosis from baseline to week 78 of antiviral therapy in chronic hepatitis B patients. (A,B) Fibrosis regression (≥1-point decrease by Ishak fibrosis score), (C,D) stable by Ishak score, and (E,F) fibrosis progression (≥1-point increase by Ishak score).